BANNER CASA GRANDE MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4M
- Transactions
- 587
- Companies
- 25
- Average per transaction
- $6,806
Who reported the payments
| Janssen Research & Development, LLC | $861,128 |
| AbbVie | $710,478 |
| Genentech, Inc. | $636,071 |
| E.r. Squibb & Sons, L.L.C. | $403,094 |
| Beigene, Ltd. | $268,747 |
| Bristol Myers Squibb | $222,373 |
| AstraZeneca | $196,431 |
| Chugai Pharmaceutical Co., Ltd. | $166,133 |
| F. Hoffmann-la Roche AG | $118,264 |
| Beone Medicines Ltd. | $95,297 |
| Siemens Medical Solutions USA, Inc. | $82,224 |
| Arthrex | $71,743 |
| Roche Molecular Systems, Inc. | $34,335 |
| Astrazeneca UK Limited | $28,479 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25,977 |
| Avid Radiopharmaceuticals, Inc. | $21,383 |
| Ferring Pharmaceuticals AS | $18,088 |
| Sanofi US Services Inc. | $10,782 |
| Servier Pharmaceuticals LLC | $10,000 |
| Johnson & Johnson | $6,000 |
| Boston Scientific | $2,944 |
| Ipsen Bioscience Inc. | $2,700 |
| Medical Device Business Services, Inc. | $1,374 |
| Olympus America Inc. | $1,000 |
| Orthofix Medical, Inc. | $3 |